Scarica l'app Stockscreener
20.91
0.38%
-0.08
Dopo l'orario di chiusura:
20.91
Sionna Therapeutics Inc Borsa (SION) Ultime notizie
What’s next for Sionna Therapeutics Inc. stock priceQuarterly Earnings Summary & Free Weekly Watchlist of Top Performers - Newser
Real time social sentiment graph for Sionna Therapeutics Inc.Trade Entry Summary & Weekly Watchlist of Top Performers - Newser
Why Sionna Therapeutics Inc. is moving todayShort Squeeze Opportunities with Indicators - Newser
Has Sionna Therapeutics Inc. found a price floorProfit Target Planning with Exit Confidence - Newser
How institutional ownership impacts Sionna Therapeutics Inc. stockValue Investing Checklist with Entry Signals - Newser
Can Sionna Therapeutics Inc. recover in the next quarterFree Watchlist for Smart Swing Trading - Newser
Why Sionna Therapeutics Inc. stock attracts strong analyst attentionShort-Term Market Movement Forecast Report - Newser
Sionna Therapeutics (NASDAQ:SION) Shares Gap Up After Better-Than-Expected Earnings - Defense World
Custom strategy builders for tracking Sionna Therapeutics Inc.Free Daily Picks With Predictable Performance - Newser
Quantitative breakdown of Sionna Therapeutics Inc. recent moveFree Stock Screener With Smart Filters - Newser
What makes Sionna Therapeutics Inc. stock price move sharplyReversal Pattern Insights with Entry Tips - Newser
Sionna Therapeutics shares rise 12.99% intraday after reporting positive Phase 1 data for SION-719 and SION-451. - AInvest
Guggenheim reiterates Buy rating on Sionna Therapeutics stock at $45 target - Investing.com Canada
Sionna Therapeutics' Q2 Net Loss Narrows - MarketScreener
Earnings Flash (SION) Sionna Therapeutics Posts Q2 Net Loss $0.41 a Share, vs. FactSet Est of $0.65 Loss - MarketScreener
Sionna Therapeutics Reports Second Quarter 2025 Financial Results - GlobeNewswire
Breakthrough in Cystic Fibrosis Treatment: Sionna's Novel Drugs Clear Phase 1, Phase 2 Trials Coming - Stock Titan
Custom strategy builders for tracking Cadrenal Therapeutics Inc.Long Term Stock Planner with Safety Checks - Newser
Using RSI to spot recovery in Sionna Therapeutics Inc.Buy and Exit Strategy Based on Momentum - Newser
Top chart patterns to watch in Sionna Therapeutics Inc.Weekly Breakout Forecast with Entry Zones - Newser
sionna therapeutics, inc. Earnings dates - RTTNews
Is Sionna Therapeutics Inc. trending in predictive chart modelsFree Trade Ready Stock Watch for Short Term - Newser
Guggenheim Initiates Sionna Therapeutics(SION.US) With Buy Rating, Announces Target Price $45 - 富途牛牛
Sentiment analysis tools applied to Sionna Therapeutics Inc.Buy Zone Strategy with Pattern Recognition - Newser
Published on: 2025-08-09 05:35:12 - Newser
Is AMRN stock reversal real or fakeLong Term Stock Growth Plan Suggestions - Newser
Certain Options of Sionna Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 6-AUG-2025. - MarketScreener
What momentum shifts mean for Sionna Therapeutics Inc.Entry Zone Watchlist With Momentum Focus - Newser
What is the dividend policy of Sionna Therapeutics Inc. stockCapitalize on momentum-driven opportunities - Jammu Links News
Should I hold or sell Sionna Therapeutics Inc. stock in 2025Build wealth steadily with proven investment strategies - Jammu Links News
Is Sionna Therapeutics Inc. a growth stock or a value stockStay informed with expert market forecasts - Jammu Links News
Is Sionna Therapeutics Inc. stock overvalued or undervaluedUnlock daily stock market insights for success - Jammu Links News
1.67%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):